Fig 4.

The amount of peripheral circulating CD19⁺CD24^hiCD38^hi cells correlated with the clinical outcome after kidney transplantation A low amount of peripheral circulating CD19⁺CD24^hiCD38^hi cells was associated with a lower eGFR (A). The orange-framed box in B indicates a subgroup of 29 patients that exhibited <1% of CD24^hi38^hi expressing CD19⁺ peripherally circulating B-cells. 31% (n = 9) of these patients experienced a biopsy proven rejection event 24 months before or after the analyses (5 patients before and 4 patients within 24 months after sample assessment).